The Prevalence of Out-patients With Rheumatoid Arthritis Fulfilling the Indication for Anti-tumor Necrosis Factor(TNFa) Therapy in General Hospital Setting in Korea: a Multi-center, Non-interventional, Observational Study
Observational
Observational Model: Case-Only, Time Perspective: Retrospective
Number of anti-TNF α agent candidates fulfilling the reimbursement guideline of Korea government in total out-patients with RA
Baseline
No
Janssen Korea, Ltd., Korea Clinical Trial
Study Director
Janssen Korea, Ltd., Korea
Korea: Institutional Review Board
CR100769
NCT01294722
December 2011
August 2012
Name | Location |
---|